Japan
· Delayed Price · Currency is JPY Kobayashi Pharmaceutical Statistics
Total Valuation
Kobayashi Pharmaceutical has a market cap or net worth of JPY 443.21 billion. The enterprise value is 392.51 billion.
| Market Cap | 443.21B |
| Enterprise Value | 392.51B |
Important Dates
The next estimated earnings date is Friday, February 7, 2025.
| Earnings Date | Feb 7, 2025 |
| Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
Kobayashi Pharmaceutical has 74.34 million shares outstanding. The number of shares has decreased by -2.24% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 74.34M |
| Shares Change (YoY) | -2.24% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 20.48% |
| Owned by Institutions (%) | 11.13% |
| Float | 37.59M |
Valuation Ratios
The trailing PE ratio is 43.62 and the forward PE ratio is 29.03.
| PE Ratio | 43.62 |
| Forward PE | 29.03 |
| PS Ratio | 2.63 |
| PB Ratio | 2.17 |
| P/TBV Ratio | 2.39 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 38.54 |
| EV / Sales | 2.33 |
| EV / EBITDA | 13.18 |
| EV / EBIT | 16.91 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.20, with a Debt / Equity ratio of 0.00.
| Current Ratio | 3.20 |
| Quick Ratio | 2.30 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.03 |
| Debt / FCF | n/a |
| Interest Coverage | 800.21 |
Financial Efficiency
Return on equity (ROE) is 4.86% and return on invested capital (ROIC) is 6.89%.
| Return on Equity (ROE) | 4.86% |
| Return on Assets (ROA) | 5.56% |
| Return on Capital (ROIC) | 6.89% |
| Revenue Per Employee | 47.76M |
| Profits Per Employee | 2.88M |
| Employee Count | 3,534 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 2.69 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -9.69% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -9.69% |
| 50-Day Moving Average | 5,746.58 |
| 200-Day Moving Average | 5,622.54 |
| Relative Strength Index (RSI) | 55.41 |
| Average Volume (20 Days) | 382,440 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Kobayashi Pharmaceutical had revenue of JPY 168.80 billion and earned 10.18 billion in profits. Earnings per share was 136.67.
| Revenue | 168.80B |
| Gross Profit | 90.97B |
| Operating Income | 23.21B |
| Pretax Income | 13.70B |
| Net Income | 10.18B |
| EBITDA | 29.79B |
| EBIT | 23.21B |
| Earnings Per Share (EPS) | 136.67 |
Balance Sheet
The company has 51.67 billion in cash and 963.00 million in debt, giving a net cash position of 50.70 billion or 682.05 per share.
| Cash & Cash Equivalents | 51.67B |
| Total Debt | 963.00M |
| Net Cash | 50.70B |
| Net Cash Per Share | 682.05 |
| Equity (Book Value) | 204.69B |
| Book Value Per Share | 2,753.50 |
| Working Capital | 87.07B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 53.89%, with operating and profit margins of 13.75% and 6.03%.
| Gross Margin | 53.89% |
| Operating Margin | 13.75% |
| Pretax Margin | 8.12% |
| Profit Margin | 6.03% |
| EBITDA Margin | 17.65% |
| EBIT Margin | 13.75% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 101.00, which amounts to a dividend yield of 1.69%.
| Dividend Per Share | 101.00 |
| Dividend Yield | 1.69% |
| Dividend Growth (YoY) | 6.32% |
| Years of Dividend Growth | 6 |
| Payout Ratio | n/a |
| Buyback Yield | 2.24% |
| Shareholder Yield | 3.93% |
| Earnings Yield | 2.29% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on June 28, 2016. It was a forward split with a ratio of 2.
| Last Split Date | Jun 28, 2016 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Kobayashi Pharmaceutical has an Altman Z-Score of 8.36.
| Altman Z-Score | 8.36 |
| Piotroski F-Score | n/a |